Teoxane SA

Holdings History for Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Symbol: RVNC
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 6,550,800 shares
Security Ownership %: 6.2%

Teoxane SA ownership in Revance Therapeutics, Inc. Common Stock, par value $0.001 per share (RVNC)

30 Jan 2025 - Teoxane SA has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,550,800 shares of Revance Therapeutics, Inc. Common Stock, par value $0.001 per share (RVNC). This represents 6.2% ownership of the company. In their previous filing dated 06 Jan 2025, Teoxane SA had reported owning 6,550,800 shares, indicating a new holding.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Price	Form	Report date	Filing time
Teoxane SA	6.2%	0%	$32,335,404	6,550,800	0	$4.94	13D/A	30 Jan 2025	30 Jan 2025, 09:01
Teoxane SA	6.2%	0%	$32,335,404	6,550,800	0	$4.94	13D/A	06 Jan 2025	06 Jan 2025, 09:00
Teoxane SA	6.2%		$32,335,404	6,550,800		$4.94	13D/A	19 Dec 2024	19 Dec 2024, 09:00